RCEL Earnings AVITA Medical, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.35 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.74 | 2026-02-12 | 10-K |
| Q3 2025 | 2025-09-30 | -1.37 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.90 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.53 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -2.39 | 2026-02-12 | 10-K |
| Q3 2025 | 2024-09-30 | -1.95 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.32 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.73 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -1.40 | 2025-02-13 | 10-K |
| Q3 2024 | 2023-09-30 | -1.12 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.78 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.37 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | 1.07 | 2024-02-22 | 10-K |
| Q3 2023 | 2022-09-30 | 0.85 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.63 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.38 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | 0.58 | 2023-02-23 | 10-K |
| Q3 2022 | 2021-09-30 | 0.69 | 2022-11-10 | 10-Q |
| FY 2022 | 2021-06-30 | 1.17 | 2023-02-23 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.